AltoStar^® HAV RT-PCR Kit 1.5

AS0241543

Products not licensed with Health Canada and not FDA cleared or approved. Kits not available in all countries.

Key features

Qualitative detection of hepatitis A virus (HAV) specific RNA
CE-IVD marked in vitro diagnostic test
Analytical sensitivity reported in IU/ml

Limit of detection (LoD)

LoD plasma

6.31 IU/ml

Sample types

The following sample types are validated for use with the AltoStar^® HAV RT-PCR Kit 1.5:

Human EDTA plasma

Human citrate plasma

Other workflows

The AltoStar^® HAV RT-PCR Kit 1.5 can be used with compatible workflows (manual or automated). Real-time PCR instruments that have been validated for use with the AltoStar^® HAV RT-PCR Kit 1.5 are:

CFX96^™ Deep Well Dx System (Bio-Rad)

CFX96^™ Dx System (Bio-Rad)

ABI Prism^® 7500 SDS (Applied Biosystems)

LightCycler^® 480 Instrument II (Roche)

QuantStudio^™ 5 Real-Time PCR System (Applied Biosystems)

Rotor-Gene^® Q5/6 plex Platform (QIAGEN)

The AltoStar^® HAV RT-PCR Kit 1.5 can be used with nucleic acid extraction systems other than the AltoStar^® AM16. Alternative procedures used for nucleic acid extraction have to be validated by the user.

Intended use

The AltoStar^® HAV RT-PCR Kit 1.5 is an in vitro diagnostic test, based on real-time PCR technology, for the qualitative detection of hepatitis A virus (HAV) specific RNA in human plasma. It is intended to be used as an aid for diagnosis of HAV infection.

AltoStar^® HAV RT-PCR Kit 1.5

Order No.	AS0241543
Rxns	96
Transportation	Dry ice
Regulatory status	CE-IVD